News
The program, called Alnylam Act ®, provides genetic testing for the diagnosis of acute hepatic porphyria, primary hyperoxaluria type 1 (PH1), and hereditary ATTR (hATTR) amyloidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback